3 | SEC Filings Hub

Filing metadata

Accession number: 0001209191-23-005349
Form type: Form 3
Filer: Spyre Therapeutics, Inc.
CIK: CIK 1636282
Filed: Jan 27, 2023
Reporting period: Nov 14, 2022
Description: Initial ownership

Documents

0001209191-23-005349-index.htm

Complete submission

0001209191-23-005349.txt

directory listing

Filed by

Spyre Therapeutics, Inc.